Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 3
1954 1
1957 1
1961 1
1963 1
1971 1
1974 1
1977 1
1978 1
1987 1
1988 2
1989 1
1990 1
1991 1
1993 2
1994 7
1995 2
1996 1
1997 2
1998 6
1999 10
2000 7
2001 11
2002 11
2003 13
2004 10
2005 16
2006 15
2007 21
2008 40
2009 36
2010 52
2011 46
2012 45
2013 40
2014 58
2015 68
2016 54
2017 37
2018 27
2019 26
2020 29
2021 32
2022 30
2023 25
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

727 results

Results by year

Filters applied: . Clear all
Page 1
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study. Tusch E, et al. Clin Infect Dis. 2024 Apr 26:ciae228. doi: 10.1093/cid/ciae228. Online ahead of print. Clin Infect Dis. 2024. PMID: 38663013
Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.
Begré L, Boyd A, Plissonnier ML, Testoni B, Salazar-Vizcaya L, Suter-Riniker F, Scholtès C, Béguelin C, Rockstroh JK, Günthard HF, Calmy A, Cavassini M, Hirsch HH, Schmid P, Bernasconi E, Levrero M, Wandeler G, Zoulim F, Rauch A; Swiss HIV Cohort Study. Begré L, et al. J Infect Dis. 2024 Apr 16:jiae189. doi: 10.1093/infdis/jiae189. Online ahead of print. J Infect Dis. 2024. PMID: 38626170 Free article.
Weight, anthropometric and metabolic changes after discontinuing antiretroviral therapy containing tenofovir alafenamide (TAF) in people with HIV.
Damas J, Munting A, Fellay J, Haerry D, Marzolini C, Tarr PE, Steffen A, Braun DL, Stoeckle M, Bernasconi E, Tshikung ON, Fux CA, Darling KEA, Béguelin C, Wandeler G, Cavassini M, Surial B; Swiss HIV Cohort Study (SHCS). Damas J, et al. Clin Infect Dis. 2024 Apr 12:ciae189. doi: 10.1093/cid/ciae189. Online ahead of print. Clin Infect Dis. 2024. PMID: 38606792 Free article.
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV.
Thoueille P, Saldanha SA, Schaller F, Choong E, Veuve F, Munting A, Cavassini M, Braun D, Günthard HF, Duran Ramirez JJ, Surial B, Furrer H, Rauch A, Ustero P, Calmy A, Stöckle M, Di Benedetto C, Bernasconi E, Schmid P, Marzolini C, Girardin FR, Buclin T, Decosterd LA, Guidi M; Swiss HIV Cohort Study. Thoueille P, et al. Among authors: furrer h. Clin Pharmacol Ther. 2024 Jun;115(6):1450-1459. doi: 10.1002/cpt.3240. Epub 2024 Mar 22. Clin Pharmacol Ther. 2024. PMID: 38519844 Free article.
Deciphering factors linked with reduced SARS-CoV-2 susceptibility in the Swiss HIV Cohort Study.
Abela IA, Hauser A, Schwarzmüller M, Pasin C, Kusejko K, Epp S, Cavassini M, Battegay M, Rauch A, Calmy A, Notter J, Bernasconi E, Fux CA, Leuzinger K, Perreau M, Ramette A, Gottschalk J, Schindler E, Wepf A, Marconato M, Manz MG, Frey BM, Braun DL, Huber M, Günthard HF, Trkola A, Kouyos RD; Swiss HIV Cohort Study. Abela IA, et al. J Infect Dis. 2024 Jan 16:jiae002. doi: 10.1093/infdis/jiae002. Online ahead of print. J Infect Dis. 2024. PMID: 38227786 Free article.
Time Trends in Causes of Death in People with HIV: Insights from the Swiss HIV Cohort Study.
Weber MSR, Duran Ramirez JJ, Hentzien M, Cavassini M, Bernasconi E, Hofmann E, Furrer H, Kovari H, Stöckle M, Schmid P, Haerry D, Braun DL, Günthard HF, Kusejko K; Swiss HIV Cohort Study. Weber MSR, et al. Among authors: furrer h. Clin Infect Dis. 2024 Jan 12:ciae014. doi: 10.1093/cid/ciae014. Online ahead of print. Clin Infect Dis. 2024. PMID: 38214897 Free article.
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Thoueille P, Saldanha SA, Schaller F, Choong E, Munting A, Cavassini M, Braun D, Günthard HF, Kusejko K, Surial B, Furrer H, Rauch A, Rougemont M, Ustero P, Calmy A, Stöckle M, Marzolini C, Di Benedetto C, Bernasconi E, Schmid P, Piso RJ, Andre P, Girardin FR, Guidi M, Buclin T, Decosterd LA; Swiss HIV Cohort Study. Thoueille P, et al. Among authors: furrer h. Lancet Reg Health Eur. 2023 Dec 13;36:100793. doi: 10.1016/j.lanepe.2023.100793. eCollection 2024 Jan. Lancet Reg Health Eur. 2023. PMID: 38162253 Free PMC article.
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2).
Griessbach A, Chammartin F, Abela IA, Amico P, Stoeckle MP, Eichenberger AL, Hasse B, Braun DL, Schuurmans MM, Müller TF, Tamm M, Audigé A, Mueller NJ, Rauch A, Günthard HF, Koller MT, Trkola A, Epp S, Amstutz A, Schönenberger CM, Taji Heravi A, Papadimitriou-Olivgeris M, Casutt A, Manuel O, Kusejko K, Bucher HC, Briel M, Speich B; Swiss HIV Cohort Study and the Swiss Transplant Cohort Study. Griessbach A, et al. Open Forum Infect Dis. 2023 Nov 3;10(11):ofad536. doi: 10.1093/ofid/ofad536. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 38023564 Free PMC article.
727 results